Early Detection of Cervical Cancer in Hard-To-Reach Population of Women Through Portable and Point-F-Care HPV Testing

Background Cervical cancer is the fourth most common cancer in women worldwide. The ELECATE project constitutes a multidisciplinary team with manufacturers and experts in Europe and the Community of States of Latin America and the Caribbean, to improve the detection of cervical cancer, especially for women of difficult access with greater risk. Although HPV vaccination and early detection of the presencer have demonstrated efficacy in cervical cancer, women do not access these programs, due to ethnic, cultural, economic and resources differences in health services. Hence the importance of investigating strategies for the early detection of cervical cancer effective and appropriate to the particularities of the population. Objectives • Identify women difficult to access in Belgium, Brazil, Ecuador and Portugal for the analysis of the barriers to the exam and the design of strategies that allow better access. • Develop efficient and commercial test for combined genomic and proteomic detection of high -risk HPV infections. Methodology Initially a qualitative study will be carried out to identify women difficult to access and barriers for preventive care. Then, for the detection of high-risk HPV, a self-troma test and portable equipment will be designed, with rapid and low-cost results. Expected results identified women of difficult access and Berreras in access to health services and availability of portable equipment for HPV detection.

OUT OF CALL – EXTERNAL FUNDS